Literature DB >> 22104005

Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease.

Morteza Izadi1, Mojgan Fazel, Seyed Hossein Sharubandi, Seyed Hassan Saadat, Maryam Moshkani Farahani, Mohammad Hassan Nasseri, Hossein Dabiri, Reza SafiAryan, Ali Akbar Esfahani, Ali Ahmadi, Nematollah Jonaidi Jafari, Reza Ranjbar, Saeed-Reza Jamali-Moghaddam, Davood Kazemi-Saleh, Mohammad Hassan Kalantar-Motamed, Saeed Taheri.   

Abstract

INTRODUCTION: Several epidemiological studies have proposed an association between Helicobacter pylori infection and coronary artery disease. In the current study, we aimed to evaluate the prevalence and relevance of H. pylori infection, using polymerase chain reaction (PCR) methods, in the coronary arterial wall of Iranian patients who have already undergone coronary bypass grafting (CABG).
METHODS: A total of 105 consecutive patients who underwent CABG at the Department of Cardiovascular Surgery of Baqiyatallah University of Medical Sciences were included in the study, and biopsy specimens from their coronary plaques were taken and analyzed using the PCR methods for detecting Helicobacter species (H Spp.). Fifty-three specimens from biopsies of the left internal mamillary artery in the same patients were also collected and tested.
RESULTS: H. Spp. PCR test result was positive for 31 (29.5%) specimens from coronary artery atherosclerotic plaques. Serologic test results also showed 25 (23.8%) positive cases for H. pylrori immunoglobulin A (IgA) and 56 (53.3%) positive for anti-H. pylori immunoglobulin G. None of the specimens from the mamillary artery were positive for H Spp. genome when it was evaluated using PCR (P<.0001). Patients with positive test result for H. pylori IgA were significantly more likely to have higher total cholesterol and low-density lipoprotein (LDL) levels than IgA-negative patients.
CONCLUSION: H Spp. infection replication in the coronary arterial wall is associated with atherosclerotic plaque formation. Seropositivity for H. pylori IgA may also enhance blood values of total cholesterol and LDL in these patients. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22104005     DOI: 10.1016/j.carpath.2011.09.011

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  15 in total

Review 1.  Helicobacter pylori: Does it add to risk of coronary artery disease.

Authors:  Vishal Sharma; Amitesh Aggarwal
Journal:  World J Cardiol       Date:  2015-01-26

2.  Unpacking the 'black box' of total pathogen burden: is number or type of pathogens most predictive of all-cause mortality in the United States?

Authors:  A M Simanek; J B Dowd; A Zajacova; A E Aiello
Journal:  Epidemiol Infect       Date:  2014-12-18       Impact factor: 4.434

3.  Association Between Helicobacter Pylori Infection and Long-term Outcome in Patients with Drug-eluting Stent Implantation.

Authors:  Rui Wang; Lei-Lei Chen; De-Zhao Wang; Bu-Xing Chen
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

4.  Comprehensive insight into immune regulatory mechanisms and vascular wall determinants of atherogenesis - emerging perspectives of immunomodulation.

Authors:  Maciej Chalubinski; Katarzyna Wojdan; Roksana Dorantowicz; Paulina Jackowska; Paulina Gorzelak; Marlena Broncel
Journal:  Arch Med Sci       Date:  2013-02-21       Impact factor: 3.318

5.  Investigating pathogen burden in relation to a cumulative deficits index in a representative sample of US adults.

Authors:  G A Noppert; A E Aiello; A M O'Rand; H J Cohen
Journal:  Epidemiol Infect       Date:  2018-06-14       Impact factor: 4.434

6.  Association of Helicobacter pylori infection with coronary artery disease: is Helicobacter pylori a risk factor?

Authors:  Jamshid Vafaeimanesh; Seyyed Fakhroldin Hejazi; Vahid Damanpak; Mostafa Vahedian; Mohammadamin Sattari; Mohammadreza Seyyedmajidi
Journal:  ScientificWorldJournal       Date:  2014-01-16

7.  Genetic Analysis of cagA and vacA Genes in Helicobacter Pylori Isolates and Their Relationship with Gastroduodenal Diseases in the West of Iran.

Authors:  Negar Souod; Mohammad Kargar; Abbas Doosti; Reza Ranjbar; Meysam Sarshar
Journal:  Iran Red Crescent Med J       Date:  2013-05-05       Impact factor: 0.611

8.  Risk of Atherosclerosis and Helicobacter pylori Infection according to CD14 Promotor Polymorphism in Healthy Korean Population.

Authors:  Sung-Goo Kang; Woo Chul Chung; Sang-Wook Song; Kyu Re Joo; Hyewon Lee; Donghoon Kang; Joune Seup Lee; Kang-Moon Lee
Journal:  Gastroenterol Res Pract       Date:  2013-10-21       Impact factor: 2.260

9.  Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection.

Authors:  Morteza Izadi; Mojgan Fazel; Reza Karbasi-Afshar; Seyed Hassan Saadat; Mohammad Hassan Nasseri; Nematollah Jonaidi-Jafari; Reza Ranjbar; Davood Kazemi-Saleh
Journal:  ARYA Atheroscler       Date:  2014-05

10.  Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.

Authors:  Asako Shimoda; Koji Ueda; Shin Nishiumi; Naoko Murata-Kamiya; Sada-Atsu Mukai; Shin-ichi Sawada; Takeshi Azuma; Masanori Hatakeyama; Kazunari Akiyoshi
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.